Standards Reporting Form: Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors Guideline from the CAP, Int Ass for the Study of Lung Cancer, and Association for Molecular Pathology - CAP US